Antibiotic resistance is one of the most pressing public health threats of our time, and over the past decade, the Pew Charitable Trusts has been at the forefront of efforts to address it. A recent independent evaluation of Pew’s antibiotic resistance project—led by experts including Sarah Moreland-Russell, an associate professor at Washington University in St. Louis—highlighted the program’s far-reaching impact.
The evaluation found that Pew played a pivotal role in strengthening policies at the FDA and USDA, advancing antibiotic stewardship standards in hospitals and food production, and fostering scientific collaboration to accelerate new drug discovery. Moreland-Russell emphasized the power of coalition-building, noting that Pew’s ability to bring together scientists, health professionals, policymakers, and industry leaders was key to driving meaningful change.
Moreland-Russell’s insights reaffirm the importance of collaboration in tackling antibiotic resistance. Pew’s decade-long campaign has demonstrated that real progress comes from uniting public health experts, private industry, and policymakers under a shared mission. As antibiotic resistance continues to evolve, this type of cross-sector partnership will be essential in preserving the effectiveness of life-saving treatments for future generations.
Read more about this evaluation here.